herenciageneticayenfermedad: Rheumatology - Nov 2, 2018 Edition :: Medical News

viernes, 2 de noviembre de 2018

Rheumatology - Nov 2, 2018 Edition :: Medical News | Medical Articles

	November 2, 2018
	Rheumatology
	The latest rheumatology news from News Medical

Turmeric for Osteoarthritis

Many people look to natural cures or remedies to help with painful conditions like osteoarthritis, and turmeric has been known for centuries for its medicinal properties. As such, turmeric has become an attractive option for treating osteoarthritis, as it can be easily bought from many high street shops.

			New campaign raises awareness for early diagnosis of rheumatic diseases The European League Against Rheumatism, EULAR, calls for people to come together on World Arthritis Day (12th October) to raise awareness of rheumatic and musculoskeletal diseases. EULAR's Don't Delay, Connect Today Campaign aims to improve early diagnosis and timely access to care to help benefit the lives of the 120 million people in Europe with RMDs.

			Meta-analysis reveals effective treatment options for urticarial vasculitis What treatments are available for patients with the rare inflammatory disease known as urticarial vasculitis? How effective are these treatments? Researchers from Charité - Universitätsmedizin Berlin embarked on a systematic review and meta-analysis to address these questions.

	Researchers discover mechanisms that lead to osteoarthritis after knee joint injury Knee joint injuries are typically related to sports, such as football, rugby or ice hockey, but people often do not know that such injuries may lead to joint inflammation and post-traumatic osteoarthritis.

	Krembil scientists develop potential treatment to stop knee and spine osteoarthritis Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks.

	Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting Gilead Sciences, Inc. and Galapagos NV today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents.

	OrthoSera presents first-in-man study results of hyperacute serum in knee osteoarthritis OrthoSera GmbH, an orthobiologics company developing serum-based solutions for musculoskeletal indications announces results of its first-in-man pilot clinical study of hyperacute serum on 36 patients in knee osteoarthritis.

	KTU researchers engineer experimental bone to help treat osteoarthritis patients Researchers from the Faculty of Chemical Technology, Kaunas University of Technology (KTU), Lithuania are developing an artificial bone, which can be used for treating of the most common joint disease - osteoarthritis.

	New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases Affecting around 2 % of the population, autoimmune rheumatic diseases can have severe symptoms, including painful and swollen joints, fever, rashes, fatigue and sensitivity to the sun, with patients needing regular check-ups.

	Study finds pain sensitization as key risk factor for persistent knee pain in osteoarthritis Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers at Université de Montréal and its affiliated Maisonneuve Rosemont Hospital Research Centre, in collaboration with researchers at Boston University.

	Researchers identify common genetic connection in lung conditions An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis.

	Near infrared spectroscopy technique for accurate evaluation of chondral injuries Osteoarthritis is a disabling disease characterised by joint pain and restricted mobility, affecting especially the elderly. The disease generally progresses slowly, even over decades.

	Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus A bioelectronic medicine device was effective in reducing pain and fatigue in patients with lupus, according to Feinstein Institute for Medical Research Professor Cynthia Aranow, MD, who will present pilot clinical trial results Tuesday at the American College of Rheumatology/Association of Rheumatology Professional's Annual Meeting.

	Outcome of ACL reconstruction related to the way you move post-surgery A third of people who undergo ACL reconstruction surgery will have osteoarthritis in their injured knee within 10 years. Within two decades, nearly 50 percent will -- terrible odds for getting a debilitating condition with no known cure.